Work

Proteasome inhibitors in cancer therapy

Year: 2017

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/nrclinonc.2016.206

Authors: Elisabet E. Manasanch, Robert Z. Orlowski

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Center for Clinical and Translational Sciences (CCTS), Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors, SWOG Network Group Operations Center of the NCTN, M. D. Anderson Cancer Center SPORE in Multiple Myeloma, Southwest Oncology Group Treatment Grant, Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma, Cancer Center Support Grant

OpenAlex ID: W2580091136

FWCI: 8.243

Cites: 155

Cited by: 1,024

Related to: 10